SCHEMBL5889200

SCHEMBL5889200

c1ccc2c(c1)c1ccccc1n2-c1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccc(-n6c7ccccc7c7ccccc76)s5)s4)s3)s2)s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.45
ATM Q13315 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GPR3 P46089 2/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
POLB P06746 1/20 0.36
ALDH1A1 P00352 2/20 0.35
AR P10275 1/20 0.33
CYP19A1 P11511 1/20 0.32
RORC P51449 2/20 0.32
BACE1 P56817 2/20 0.31
KMT2A Q03164 2/20 0.31
MAPT P10636 3/20 0.31
LMNA P02545 2/20 0.31
HTT P42858 2/20 0.31
MEN1 O00255 1/20 0.31
HPGD P15428 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5889191 1.00 KDM4E (0.45) KDM4EATML3MBTL1GPR3CYP1A2
SCHEMBL5889208 1.00 KDM4E (0.45) KDM4EATML3MBTL1GPR3CYP1A2
SCHEMBL5889245 1.00 KDM4E (0.45) KDM4EATML3MBTL1GPR3CYP1A2
SCHEMBL5889212 0.98 KDM4E (0.46) KDM4EATML3MBTL1GPR3CYP1A2
SCHEMBL13912325 0.87 KDM4E (0.52) KDM4EATML3MBTL1GPR3CYP1A2
SCHEMBL9890906 0.82 KDM4E (0.41) KDM4EATML3MBTL1GPR3POLB
SCHEMBL12699708 0.82 TSPO (0.41) KDM4EATML3MBTL1POLBALDH1A1
SCHEMBL13309229 0.82 RXRA (0.38) KDM4EATML3MBTL1POLBALDH1A1
SCHEMBL9890877 0.81 NQO2 (0.38) KDM4EATML3MBTL1GPR3CYP1A2
SCHEMBL13801135 0.81 KDM4E (0.36) KDM4EATML3MBTL1GPR3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6986952-B2 Chemical compound capable of emitting visible light, and luminescent material, electro-luminescent device, and display apparatus that contain the chemical compound MITSUMI ELECTRIC CO., LTD. (JP) 2006-01-17 US disclosed
US-20040166363-A1 Chemical compound capable of emitting visible light, and luminescent material, electro-luminescent device, and display apparatus that contain the chemical compound MITSUMI ELECTRIC CO., LTD. 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040166363-A1 Chemical compound capable of emitting visible light, and luminescent material, electro-luminescent device, and display apparatus that contain the chemical compound EML4, DDT, EED KDM4E 1549/4885ATM 3505/4885L3MBTL1 293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.